DEUCRAVACITINIB

2976 reported adverse events

Drug classes: Tyrosine Kinase 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking DEUCRAVACITINIB:

# Side effect Count
0 DRUG INEFFECTIVE 286
1 ACNE 255
2 PRURITUS 244
3 RASH 206
4 PSORIASIS 190
5 ERYTHEMA 171
6 OFF LABEL USE 120
7 SKIN BURNING SENSATION 88
8 PRODUCT DOSE OMISSION ISSUE 83
9 ADVERSE EVENT 82
See all common reactions for DEUCRAVACITINIB

DEUCRAVACITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALPHA-2 MACROGLOBULIN INCREASED 1 0.1667
1 GALLBLADDER CANCER RECURRENT 1 0.1000
2 ORAL PURPURA 1 0.0909
3 FOLLICULITIS GENITAL 1 0.0769
4 CONJUNCTIVAL MELANOMA 1 0.0588
5 PSORIASIS AREA SEVERITY INDEX INCREASED 7 0.0424
6 ANAL BLISTER 1 0.0250
7 TOXOCARIASIS 1 0.0250
8 OLFACTORY DYSFUNCTION 1 0.0238
9 FATTY LIVER ALCOHOLIC 1 0.0172
See all enriched reactions for DEUCRAVACITINIB